ONCY — Oncolytics Biotech Share News
0.000.00%
Brief: Oncolytics Biotech announces colorectal cancer phase 2 study in female patients
Brief: Oncolytics Biotech Q1 loss 3 cents/shr
Brief: Oncolytics Biotech reports updated data from Phase 2 study of REOLYSIN
Brief: Oncolytics says ovarian cancer drug shows benefit in mid-stage study
Brief: Oncolytics Biotech qtrly loss per share $0.02
Amgen wins EU green light for first virus-based cancer drug (updated)
Amgen's virus-based cancer drug wins European green light
Brief: Oncolytics announces phase 1b study in advanced pancreatic cancer
U.S. STOCKS ON THE MOVE-Alibaba, Twitter, Starwood, Humana
Market Pulse: Green Mountain Coffee, Cliffs Natural, Abercrombie & Fitch
Market Pulse: Apple, Caesar's Entertainment, LinkedIn, Zynga
Market Pulse: McDonald's, Enteromedics, Oncolytics, Tranzyme
Market Pulse: McDonald's, Enteromedics, Oncolytics, Tranzyme
Marketpulse: Mcdonald's, Enteromedics, Oncolytics, Tranzyme
Market Pulse: Oncolytics, SolarCity, RIM, Charles River, Delta Air Lines, Deckers, Marcus
Market Pulse: Oncolytics, SolarCity, RIM, Charles River, Delta Air Lines, Deckers, Marcus
Market Pulse: Oncolytics, SolarCity, RIM, Delta Air Lines, Deckers, Marcus
Market Pulse: Oncolytics, SolarCity, RIM, Delta Air Lines, Best Buy, Marcus, RF Micro